Animal and human RNA viruses: genetic variability and ability to overcome vaccines
ARCHIVES OF MICROBIOLOGY
Authors: Villa, T. G.; Abril, Ana G.; Sanchez, S.; de Miguel, T.; Sanchez-Perez, A.
Abstract
RNA viruses, in general, exhibit high mutation rates; this is mainly due to the low fidelity displayed by the RNA-dependent polymerases required for their replication that lack the proofreading machinery to correct misincorporated nucleotides and produce high mutation rates. This lack of replication fidelity, together with the fact that RNA viruses can undergo spontaneous mutations, results in genetic variants displaying different viral morphogenesis, as well as variation on their surface glycoproteins that affect viral antigenicity. This diverse viral population, routinely containing a variety of mutants, is known as a viral 'quasispecies'. The mutability of their virions allows for fast evolution of RNA viruses that develop antiviral resistance and overcome vaccines much more rapidly than DNA viruses. This also translates into the fact that pathogenic RNA viruses, that cause many diseases and deaths in humans, represent the major viral group involved in zoonotic disease transmission, and are responsible for worldwide pandemics.
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease
INFECTION AND CHEMOTHERAPY
Authors: Seo, Yu Bin; Moon, Su-Jin; Jeon, Chan Hong; Song, Joon Young; Sung, Yoon-Kyoung; Jeong, Su Jin; Kwon, Ki Tae; Kim, Eu Suk; Kim, Jae-Hoon; Kim, Hyoun-Ah; Park, Dong-Jin; Park, Sung-Hoon; Park, Jin Kyun; Ahn, Joong Kyong; Oh, Ji Seon; Yun, Jae Won; Lee, Joo-Hyun; Lee, Hee Young; Choi, Min Joo; Choi, Won Suk; Choi, Young Hwa; Choi, Jung-Hyun; Heo, Jung Yeon; Cheong, Hee Jin; Lee, Shin-Seok
Abstract
To develop a clinical practice guideline for vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), the Korean College of Rheumatology and the Korean Society of Infectious Diseases developed a clinical practice guideline according to the clinical practice guideline development manual. Since vaccination is unlikely to cause AIIRD or worsen disease activities, required vaccinations are recommended. Once patients are diagnosed with AIIRD, treatment strategies should be established and, at the same time, monitor their vaccination history. It is recommended to administer vaccines when the disease enters the stabilized stage. Administering live attenuated vaccines in patients with AIIRD who are taking immunosuppressants should be avoided. Vaccination should be considered in patients with AIIRD, prior to initiating immunosuppressants. It is recommended to administer influenza, Streptococcus pneumoniae, hepatitis A, hepatitis B, herpes zoster, measles-mumps-rubella virus, human papillomavirus, and tetanus-diphtheria-pertussis vaccines in patients with AIIRD; such patients who planned to travel are generally recommended to be vaccinated at the recommended vaccine level of healthy adults. Those who live in a household with patients with AIIRD and their caregivers should also be vaccinated at levels that are generally recommended for healthy adults.